CD8+ CTL RECOGNITION OF MHC CLASS 1
MHC 1 类的 CD8 CTL 识别
基本信息
- 批准号:6373153
- 负责人:
- 金额:$ 30.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-09-30 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from the Investigator's abstract): The hallmark of the
immune system is the remarkable ability to discriminate between self and
foreign proteins displayed as peptides bound to self-major histocompatibility
complex (MHC) molecules. T lymphocytes acquire this ability during development
in the thymus in which low avidity interactions between T-cell receptors (TCRs)
and self-MCH/peptide result in positive selection. High avidity interactions in
the thymus result in negative selection and deletion of potentially
autoreactive T-cell repertoire that is self-tolerant and self-MHC restricted.
TCR affinity, MHC/peptide density and co-receptor engagement contribute to the
overall avidity of the interaction between T-cells and antigen presenting cell
(APC). This avidity sets up a balance between positive and negative selection
and establishes the activation requirements of peripheral T-cells. The overall
goal of this application is to correlate the thymic selection environment with
the functional phenotype of the peripheral CD8T cell repertoire. Specificity of
peripheral CD8 T-cells. To do this they will alter class I expression or CD8
interaction during thymic development and determine how it affects the ability
of peripheral CD8 T-cells to distinguish APC expressing different levels of
class I/peptide complexes. To address these questions, unique MHC Class I
transgenic mice that express a single class I allele will be engineered. Using
these mice, the diversity of the CD8 T-cell repertoire selected by a single
class I allele, in the absence of other class I molecules, will be
characterized. These analyses will probe mechanisms of tolerance to
self-antigens and avoidance of autoimmune responses. Furthermore these studies
will determine factors influencing activation requirements of self-restricted
responses to tumor antigens and infectious virus as well as how individual MHC
alleles contribute to alloreactive responses and transplantation tolerance.
描述(改编自研究者的摘要):这是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JANET M CONNOLLY其他文献
JANET M CONNOLLY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JANET M CONNOLLY', 18)}}的其他基金
CD8-LYT-2 RECOGNITION OF THE CLASS I ALPHA 3 DOMAIN
CD8-LYT-2 对 I 类 ALPHA 3 结构域的识别
- 批准号:
3141829 - 财政年份:1989
- 资助金额:
$ 30.8万 - 项目类别:
CD8-LYT-2 RECOGNITION OF THE CLASS I ALPHA 3 DOMAIN
CD8-LYT-2 对 I 类 ALPHA 3 结构域的识别
- 批准号:
3141824 - 财政年份:1989
- 资助金额:
$ 30.8万 - 项目类别:
相似海外基金
Elucidating a molecular understanding of ILC2 MHC class I antigen cross priming
阐明 ILC2 MHC I 类抗原交叉引发的分子理解
- 批准号:
486527 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Studentship Programs
Restoring MHC class I antigen presentation to enhance anti-tumour immunity
恢复MHC I类抗原呈递,增强抗肿瘤免疫力
- 批准号:
nhmrc : GNT1164054 - 财政年份:2020
- 资助金额:
$ 30.8万 - 项目类别:
Project Grants
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
8996707 - 财政年份:2014
- 资助金额:
$ 30.8万 - 项目类别:
Ubiquitin conjugation and direct MHC class I antigen presentation
泛素结合和直接 MHC I 类抗原呈递
- 批准号:
8880646 - 财政年份:2014
- 资助金额:
$ 30.8万 - 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
9206412 - 财政年份:2014
- 资助金额:
$ 30.8万 - 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
8723605 - 财政年份:2014
- 资助金额:
$ 30.8万 - 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
8072956 - 财政年份:2010
- 资助金额:
$ 30.8万 - 项目类别:
The function of the Ubiquitin-Proteasome-System (UPS) in MHC class I antigen processing in target cells and maturing human dendritic cells (hDCs).
泛素蛋白酶体系统 (UPS) 在靶细胞和成熟人树突细胞 (hDC) 中 MHC I 类抗原加工中的功能。
- 批准号:
105348415 - 财政年份:2009
- 资助金额:
$ 30.8万 - 项目类别:
Research Grants
In vivo analysis of the imnportance of proteasome immunosubunits and of PA28 for MHC class I antigen processing, CTL response induction and tumor-virus elimination (A 7)
体内分析蛋白酶体免疫亚基和 PA28 对于 MHC I 类抗原加工、CTL 反应诱导和肿瘤病毒消除的重要性 (A 7)
- 批准号:
5354871 - 财政年份:2002
- 资助金额:
$ 30.8万 - 项目类别:
Collaborative Research Centres
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
7991835 - 财政年份:2001
- 资助金额:
$ 30.8万 - 项目类别: